CTRE vs JAN Stock Comparison

CareTrust REIT and Janus Living Prices as of Nov 13, 2026 Peers: Industry group
CTRE CareTrust REIT, Inc.
$38.08 +4.9% 1M +6.5% 1Y
Market cap
$9.80B
P/E
25.2x
Revenue (TTM)
$615.35M
Div. yield
3.95%
Healthcare REITs Real Estate
7 wins
JAN Janus Living, Inc.
$31.82 +9.8% 1M
Market cap
$7.46B
P/E
–
Revenue (TTM)
$835.56M
Div. yield
1.29%
Healthcare REITs Real Estate

Head to Head

7 decided of 12

CareTrust REIT leads on 7 of the 12 questions below (CareTrust REIT 7). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCTREJANLeader
Larger companyMarket capitalisation $9.80B $7.46B CTRE
Cheaper on earningsLower P/E, profitable companies only 25.2x -3,327x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 23.5x 318.2x CTRE
Faster revenue growthRevenue growth, trailing twelve months +43.6% — –
More profitableNet margin, trailing twelve months 59.2% -0.3% CTRE
Better return on capitalReturn on invested capital 7.2% -21.2% CTRE
Less leveragedLower net debt / EBITDA 1.3x — –
Higher dividend yieldTrailing dividend yield 3.95% 1.29% CTRE
Better 1-year returnPrice return, last 12 months +6.5% — –
Better 5-year returnAnnualised price return, 5 years +12.9%/yr — –
Less volatileAnnualised volatility, 1 year 25.3% 28.9% CTRE
Higher overall scoreMean of the five percentile scores vs peers 70/100 25/100 CTRE

Percentile Scorecard

CTREJAN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCTREJAN
Valuation 21 #118 of 149 1 #147 of 149
Growth 95 #9 of 147 –
Profitability 78 #33 of 144 26 #107 of 144
Financial Health 98 #4 of 149 72 #43 of 149
Shareholder Returns 58 #59 of 139 2 #136 of 139
Overall 70 25
  • CTRE ranked among 150 companies in Property REITs
  • JAN ranked among 150 companies in Property REITs

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCTREJANSPY
1 month +4.9%+9.8% -2.0%
3 months -1.8%+3.9% -2.8%
6 months -7.4%+19.3% +2.0%
Year to date +5.3%— +10.6%
1 year +6.5%— +12.2%
3 years +65.9%— +68.1%
3 years, per year +18.4%— +18.9%
5 years +83.4%— +61.4%
5 years, per year +12.9%— +10.1%
10 years +181.0%— +248.5%
10 years, per year +10.9%— +13.3%

Risk

MeasureCTREJANSPY
Volatility, 1Y 25.3%28.9% 13.6%
Downside volatility, 1Y 25.8%26.9% 13.9%
Beta vs S&P 500, 1Y 0.04-0.01 1.00
Return / volatility, 1Y 0.26— 0.90
Max drawdown, 5Y -30.1%-13.8% -25.4%
From 52-week high -12.2%-3.2% -3.2%
52-week high $43.39$32.88 $779.14
52-week low $35.45$22.88 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCTREJAN
P/E now vs peer median 25.2xmedian 26.1x -3,327xmedian 26.1x
P/S now vs peer median 15.9xmedian 4.3x 8.9xmedian 4.3x
EV/EBITDA now vs peer median 19.0xmedian 14.5x -10.9xmedian 14.5x
P/FCF now vs peer median -10.6xmedian 21.4x -3.5xmedian 21.4x
P/B now vs peer median 1.8xmedian 1.2x 1.8xmedian 1.2x
PEG now vs peer median 0.45median 1.75 —median 1.75

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCTREJAN
Revenue $615.35M $835.56M
Operating income – -$871.49M
Net income $364.15M $38.54M
Free cash flow -$921.23M -$2.15B
EPS (diluted) $1.51 $-0.01
Cash & equivalents $479.88M $338.06M
Total debt $1.18B –
Shares (diluted) 241.09M 225.97M
Enterprise value $8.89B $5.61B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCTREJAN
P/E 25.2x -3,327x
P/FCF -10.6x -3.5x
P/Operating cash flow 19.6x 30.0x
P/S 15.9x 8.9x
P/B 1.8x 1.8x
P/Tangible book 1.8x 2.0x
EV/EBITDA 19.0x -10.9x
EV/EBIT 24.6x -8.2x
EV/Revenue 17.1x 8.5x
EV/FCF -11.4x -3.3x
EV/Operating cash flow 21.0x 28.7x
PEG (3Y EPS CAGR) 0.45 –

Growth

14 metrics
MetricCTREJAN
Revenue growth (1Y) 43.6% –
Revenue CAGR (3Y) 43.1% –
Gross profit growth (1Y) – –
Gross profit CAGR (3Y) – –
Operating income growth (1Y) – –
Operating income CAGR (3Y) – –
Net income growth (1Y) 39.3% –
Net income CAGR (3Y) 105.7% –
EPS growth (1Y) 22.7% –
EPS CAGR (3Y) 55.6% –
Operating cash flow growth (1Y) 43.8% –
Operating cash flow CAGR (3Y) 50.9% –
Free cash flow growth (1Y) 14.0% –
Free cash flow CAGR (3Y) -143.7% –

Profitability

14 metrics
MetricCTREJAN
Gross margin – –
EBITDA margin 89.7% -78.3%
Operating margin – -104.3%
Pretax margin 60.4% 4.7%
Net margin 59.2% -0.3%
FCF margin -149.7% -257.6%
Operating cash flow margin 81.4% 29.7%
Return on equity 7.4% 1.0%
Return on assets 5.3% 0.8%
Return on invested capital 7.2% -21.2%
Return on capital employed – –
Asset turnover 0.1x 0.2x
Cash conversion (OCF / net income) 1.4x 6.4x
Stock comp / revenue 1.9% 0.1%

Financial Health

11 metrics
MetricCTREJAN
Debt / assets 15.2% –
Debt / equity 0.2x –
Net debt / EBITDA 1.3x –
Debt / FCF -1.3x –
Liabilities / assets 30.7% 21.0%
Equity / assets 69.3% 79.0%
Interest coverage 7.7x -407.8x
Current ratio – –
Quick ratio – –
Cash ratio – –
Altman Z-score – –

Shareholder Returns

7 metrics
MetricCTREJAN
Dividend yield 4.0% 1.3%
Net buyback yield -13.7% -11.2%
Shareholder yield -9.7% -9.9%
Payout ratio (earnings) 90.7% –
Payout ratio (FCF) -35.8% –
Dividend growth (1Y) 41.0% –
Dividend CAGR (3Y) 44.4% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCTREJAN
Forward P/E 23.5xFY2026 318.2xFY2026
EPS, next fiscal year $1.62FY2026 $0.10FY2026
EPS growth, next FY +3.2%FY2026 +150.0%FY2026
EPS growth, the year after +9.3% -10.0%
Revenue, next fiscal year $534.24MFY2026 $885.94MFY2026
Revenue growth, next FY +45.1%FY2026 +27.8%FY2026
Revenue growth, the year after +17.3% +42.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCTREJAN
Held by institutions 100.0% 38.1%
Institutions holding 516 162
Change in shares held, QoQ +8.8% +56.8%
Institutions buying 283 137
Institutions selling 163 19
Buyers to sellers 1.74 7.21

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CTREJAN
CTRE 1.00 0.51
JAN 0.51 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CTRE and JAN?

CareTrust REIT (CTRE) is the largest by market capitalisation: CareTrust REIT (CTRE) $9.80B, Janus Living (JAN) $7.46B.

Which company is more profitable?

CareTrust REIT (CTRE) has the highest net margin (CareTrust REIT (CTRE) 59.2%, Janus Living (JAN) -0.3%). On return on invested capital, CareTrust REIT (CTRE) leads (CareTrust REIT (CTRE) 7.2%, Janus Living (JAN) -21.2%).

Which pays a higher dividend?

CareTrust REIT (CTRE) has the highest dividend yield: CareTrust REIT (CTRE) 3.95%, Janus Living (JAN) 1.29%.

Which stock is riskier?

By one-year price volatility, CareTrust REIT (CTRE) has been the steadiest (CareTrust REIT (CTRE) 25.3%, Janus Living (JAN) 28.9%). Volatility measures how widely the price swings, not the risk of the business.

Do CTRE and JAN move together?

Their daily returns over the past year have a correlation of 0.51, a moderate positive relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, CTRE and JAN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, CareTrust REIT (CTRE) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.